Ferdi Öztürk

Dr. Ferdi Öztürk

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
FÖFerdi Öztürk
Ferdi Öztürk
CÜCansu Irmak Ünlü
Cansu Irmak Ünlü
HSHayriye Sarıcaoğlu
Hayriye Sarıcaoğlu
KAKenan Aydoğan
Kenan Aydoğan
ŞEŞahin Erdöl
Şahin Erdöl

22 August 2025 in Cureus
Verified
Journal Article
Open access
PDF file
FÖFerdi Öztürk
Ferdi Öztürk
SÖSerap Öztürkcan
Serap Öztürkcan
EEErhan Eser
Erhan Eser
MSMustafa Turhan Sahin
Mustafa Turhan Sahin
Objective Despite the increase in incidence of non-melanoma skin cancers (NMSC), deaths are relatively rare. The goal of treatment is to prevent the recurrence of the disease and to increase the quality of life (QoL). The QoL and the cost of treatment are becoming more important treatment goals, as nowadays NMSC are rarely life-threatening. This study aims to assess and compare the QoL in patients with NMSC, psoriasis, and vitiligo using three validated QoL instruments. Methods A total of 150 patients were included in this study, with 50 patients each diagnosed with NMSC, psoriasis, and vitiligo. The QoL was assessed using the European Organization for Research and Treatment of Cancer Core QoL Questionnaire (EORTC QLQ-C30), the Dermatology Life Quality Index (DLQI), and the World Health Organization Quality of Life Scale Short Form (WHOQOL-BREF). Sociodemographic data and disease severity were also recorded. Results The study found that NMSC and psoriasis patients had similar QoL scores, with both groups showing more significant impairment in QoL than vitiligo patients. Psoriasis patients experienced greater deterioration in daily activities and personal relationships, while QoL in work, school, and treatment domains was worse in both NMSC and psoriasis patients compared to vitiligo patients. A negative correlation was observed between disease duration and the physical health domain subscale of the WHOQOL-BREF, as well as the work and school subscale of the DLQI, in vitiligo patients; and between disease duration and the work and school subscale of the DLQI in NMSC patients. Conclusion The findings underscore the significant impact of NMSC on patients’ QoL, highlighting the importance of comprehensive management strategies in these conditions. The similarity in QoL scores obtained across all groups using DLQI and WHOQOL-BREF suggests that the WHOQOL-BREF, a general health QoL scale, can be effectively used alongside the DLQI, a dermatology-specific QoL scale, to assess QoL in dermatologic diseases.

9 April 2026 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
BÇBüşra Çalışır
Büşra Çalışır
SYSezen Yusuf
Sezen Yusuf
SASecil AK-AKSOY
Secil AK-AKSOY
FÖFerdi Öztürk
Ferdi Öztürk
ŞAŞaduman Balaban Adım
Şaduman Balaban Adım
BEBeyza Ener
Beyza Ener

30 January 2026 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
FÖFerdi Öztürk
Ferdi Öztürk
HBHüseyin Bezir
Hüseyin Bezir
ŞAŞaduman Balaban Adım
Şaduman Balaban Adım
HSHayriye Sarıcaoğlu
Hayriye Sarıcaoğlu
Introduction: Prurigo pigmentosa (PP) is a rare inflammatory skin disease, first described in 1971 in Japan. The condition is characterized by the abrupt appearance of pruritic, erythematous, maculopapular lesions that typically resolve within several days to weeks, resulting in reticulated hyperpigmentation. Objective: This study aimed to retrospectively evaluate six cases of prurigo pigmentosa in light of clinical and histopathological features and treatment responses. Methods: This retrospective study was performed at the Department of Dermatology, Bursa Uludag University Faculty of Medicine, Bursa, Türkiye, from 2022 to 2025. Six patients were included in the study, and their demographic characteristics, presenting complaints, clinical and histopathological findings, laboratory results, and treatment responses were assessed. Results: Six patients with prurigo pigmentosa were evaluated. All presented with symmetrical, pruritic erythematous eruptions on the trunk and back. Three had a history of ketogenic diet or rapid weight loss. Five patients received oral doxycycline (100–200 mg/day) and demonstrated marked clinical improvement. One patient initially treated with corticosteroids showed worsening and was switched to doxycycline. Histopathology revealed spongiotic dermatitis (N=3), eosinophilic infiltration (N=2), and interface dermatitis (N=1). Elevated serum IgE levels were detected in two cases. Conclusion: In conclusion, prurigo pigmentosa should be suspected in young patients with symmetric pruritic eruptions and a history of ketosis. Awareness of its variable histopathological findings and its strong association with dietary or metabolic triggers is essential to timely diagnosis. The rapid and consistent response to tetracycline-class antibiotics, particularly doxycycline, underscores their value as both a diagnostic aid and a preferred therapeutic option.

28 November 2025 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
BDBatuhan Mustafa Demir
Batuhan Mustafa Demir
FÖFerdi Öztürk
Ferdi Öztürk
HSHayriye Sarıcaoğlu
Hayriye Sarıcaoğlu

17 August 2026 in International Journal of Dermatology
Verified
Journal Article
Closed access
YTYunus Toso
Yunus Toso
SISidar İlIk
Sidar İlIk
FÖFerdi Öztürk
Ferdi Öztürk
ÜŞÜmmühan Şeker
Ümmühan Şeker
ŞAŞaduman Balaban Adım
Şaduman Balaban Adım
HSHayriye Sarıcaoğlu
Hayriye Sarıcaoğlu